Chemotherapy in non-small cell lung cancer: opportunities for advancement
10.1186/s40880-016-0119-x
Saved in:
Main Authors: | Akhtari, M, Bernicker, E.H, Teh, B.S |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/183326 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer
by: Chong, C.F., et al.
Published: (2011) -
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials
by: Ku, G.Y., et al.
Published: (2016) -
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspective
by: Tan, P.-T, et al.
Published: (2020) -
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites
by: Thuya, WL, et al.
Published: (2023) -
A merged lung cancer transcriptome dataset for clinical predictive modeling
by: Lim, S.B, et al.
Published: (2020)